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DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING
April 21, 2020

Executive Summary
NM updates. YesNM assistance. Ventilator production. Georgia reopening. Wisconsin legal challenge. Pending
immigration suspension. Religious restriction parity. Hong Kong restrictions. Global food shortages. Mexico
rapid spread. Oil futures negative. Socio-economic implications. Clinical disease patterns. Healthcare worker
testing. WHO courses. Vaccine volunteers to be infected. Intervention impacts. Social distancing tribal. NIH
releases treatment guidelines. Guidelines on: thromboembolism Tx, IBD endoscopy, vascular surgery,
nutritional management, cutaneous lymphomas, cardiac surgery triage, cellular therapy. LA has 40X known
cases. At-home testing. ELISA diagnostic tool. CRISPR vs. PCR. Testing coordination. Hydroxychloroquine
prophylaxis. VA hydroxychloroquine study. 52 new clinical trials. Coagulation disorders. Cardiac injury.
Ansomia features. D-dimer risk. Early warning scores. Artificial intelligence review.
Our continuously curated practice guidelines in the context of COVID-19 can be found here.
You may submit content for future briefings here.

NM Highlights


7 new deaths and 103 additional confirmed COVID-19 cases reported in NM
The total positive cases and total deaths in the state are 2,072 and 65, respectively. As of today, the state has performed
40,877 tests, there are 119 individuals currently hospitalized for COVID-19, and 529 COVID-19 cases have recovered. New
NMDOH portal featuring epidemiologic breakdown of cases.



YesNM offers temporary assistance for needy families (TANF) and other resources
YesNM is offering TANF, energy assistance, medical assistance, and food assistance. Apply online or use their customer
service line: 1-800-283-4465.

US Highlights


U.S. increases ventilator production as predicted need decreases
U.S. started a $2.9 billion program to build 187,000 ventilators, which is significantly more than the 16,631 invasive
ventilators needed that the Institute for Health Metrics and Evaluation currently forecasts. The number of invasive and noninvasive ventilators set to be built has not been released. Surplus ventilators will be sent to other countries in need.



Georgia tests boundaries of resuming “normal” life post-pandemic with 'risky' reopening
No states have met basic White House guidelines of a 2 week decline in cases to reopen. Georgia has been hit hardest, with
19,000 cases and nearly 800 deaths, including a dense cluster in the state’s southwest. Amid a national debate over how to
fight the virus while mitigating the deep economic toll, these moves are the first to test borders of resuming “normal” life.



Wisconsin Republicans file lawsuit challenging coronavirus stay-at-home order
Republican lawmakers in Wisconsin filed a lawsuit against Democratic Governor Tony Evers, challenging his stay-at-home
order. The lawsuit asks the Wisconsin Supreme Court to issue a temporary injunction on the state’s order that was extended
until May 26 by the Wisconsin’s Department of Health Services secretary last week as directed by the governor.



President Trump plans to sign executive order to temporarily suspend immigration to the US
"In light of the attack from the Invisible Enemy, as well as the need to protect the jobs of our GREAT American Citizens, I will
be signing an Executive Order to temporarily suspend immigration into the United States!", President Trump tweeted late on

Monday (4/20). Over the past four weeks, more than 20 million Americans have registered for unemployment benefits. That
amounts to roughly as many jobs as employers had added over the previous decade.



US Attorney General opposes restrictions on religious activity not applied to nonreligious activity
US Attorney General William P. Barr stated, in response to a recent Mississippi church case, that while restrictions on
constitutional rights are reasonable during times of emergencies, the government cannot allow restaurants, theaters, and
other venues to remain open while ordering houses of worship to close.

International Highlights


Less severe restrictions in Hong Kong successfully reduced spread
Perceived severity of COVID increased voluntary behavioral changes in Hong Kong which has also effectively dropped
influenza rates. Government tracing was both exhaustive and effective at containing active cases. http://doi.org/dsfw Hong
Kong slowed the spread of SARS-CoV-2 through a combination of intensive surveillance, quarantining and social distancing
without relying on severe measures used elsewhere. See a round-up of the latest #COVID19 research.



World Food Program warns of food shortages
A report estimates that the number suffering from hunger may increase from 135 million to more than 250 million. Those
most at risk are in 10 countries affected by conflict, economic crisis and climate change.



Mexico reports rapid spread and calls for public adherence to social distancing
On April 20, Mexico reported 511 new cases for a total of 8,772 cases. Due to the limited testing capacity, the total number
of cases is expected to be higher at 55,951 cases across the country. Further social distancing efforts are being made.

Economics, Workforce, Supply Chain, PPE Highlights


U.S. oversupplies oil and futures price per barrel settles at -$37.63 for US benchmark
Due to excessive supply and lower demand, US oil price dropped on Monday (4/20). Currently, there are 19.3 million barrels
of crude stock and 21 million barrels of storage space available, which is expected to be filled by the end of May. Potential
solutions include transporting the oil to offshore storage or selling to the US Strategic Petroleum Reserve and storing the oil
in the ground.



A review of the socio-economic implications of COVID-19 pandemic
In a review article in International Journal of Surgery the authors summarize the effect of COVID-19 on individual aspects of
the world economy, focusing on primary sectors which include industries involved in the extraction of raw materials,
secondary sectors involved in the production of finished products and tertiary sectors to include all service provision
industries.

Epidemiology Highlights


Fatality rate associated with cumulative cases and negatively associated with intensity of testing
The flattening-the-curve hypothesis was tested by assessing the association between case fatality rate and cumulative
number of COVID-19 infections/100,000 inhabitants. The analysis controlled for age of the epidemic, COVID-19 testing
intensity, and health expenditure per capita. Case fatality rate was positively associated with cumulative number of cases
and negatively associated with the intensity of testing. Countries that have slowed the spread have been able to reduce
mortality by not overwhelming their hospitals.

Healthcare Policy Recommendations


Healthcare worker testing: an in-hospital transmission reduction strategy
Testing of both symptomatic and asymptomatic healthcare workers is important in curtailing spread of SARS-CoV-2. By the
provision of adequate PPE, the wellbeing of HCWs can be promoted by ensuring that infected colleagues are promptly tested

and isolated.



WHO offers self-paced online courses on COVID-19
Training includes an introduction to COVID-19, health and safety, prevention and control, clinical care, country capacitation,
treatment facilities, and field data tools. Courses range from 15 minutes to 10 hours.



United States lawmakers want volunteers to be infected with coronavirus to test vaccines
35 US lawmakers are supporting regulators in the US to embrace the controversial strategy of intentionally infecting
volunteers with SARS-CoV-2 in order to accelerate the development of an effective vaccine. The lawmakers also back the idea
of parallel, simultaneous testing of different doses of a vaccine—as opposed to the traditional practice of sequential testing.



Impact of various interventions on reduction of new cases
MedRxiv preprint: Model informed by multinational data, including US, compares the effectiveness of non-pharmaceutical
interventions in early stages of outbreak. Closure of venues is associated with the largest reduction (33%; 95% CI 16-47 %).
The reduction is next highest for work bans on non-essential business activities (28%; 95% CI 10-42 %) and border closures
(26 %; 95% CI 13–37 %). School closures yield a reduction of only (11% 95% CI 0-27 %) and its relative impact is one of the
lowest among the various policy measures considered in this analysis.



How to cope with social distancing in tribal communities with local COVID-19 transmission
Social distancing lowers the chances of spreading illness between people, but it may prevent people from following some
traditional and ceremonial practices. This may be especially relevant for American Indian/Alaska Native (AI/AN) communities.
CDC guidelines for how to cope with social distancing in the tribal communities are presented here.

Practice Guidelines


NIH treatment guidelines advise against exposure prophylaxis
NIH panel does not recommend any drug for pre- or post-exposure prophylaxis outside of clinical trials. It neither makes
recommendation for any specific antiviral or immunomodulatory treatments, as no drug was proven to be safe and effective.
Certain therapies can be used under investigation (summary of studies provided). They advised against hydroxychloroquineazithromycin due to toxicity, against HIV protease inhibitors due to lack of trial results and unfavorable pharmacodynamics,
against interferons and Janus kinase inhibitors, and against systemic corticosteroids for mechanically ventilated adults with
COVID-19 without ARDS. Low-dose corticosteroids are preferred over no corticosteroids in patients with refractory shock.



Diagnosis and treatment of suspected venous thromboembolism during COVID-19
This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for
COVID-19 patients. A committee was comprised of vascular thrombosis experts, vascular surgeons, vascular medicine
physicians, and vascular technologist.



Endoscopy in inflammatory bowel disease during and after COVID-19 pandemic
The Lancet reports: The authors highlight different scenarios in which endoscopy should still be performed urgently in
patients with IBD, as well as recommendations regarding the use of PPE. They suggest a pathway for performing safe
endoscopy and discuss the potential risks of postponing endoscopy in IBD. Also, they propose a post-pandemic plan for
access to endoscopy.



Vascular surgery department adjustments during COVID-19 pandemic
Portuguese report on managing the largest Lisbon clinic's vascular surgery department.



ESPEN guidance for nutritional management of individuals with SARS-CoV-2
European Society for Clinical Nutrition and Metabolism (ESPEN) provides guidance for nutritional management of COVID-19
patients by proposing 10 practical recommendations. The guidance is focused to those in the ICU or in the presence of older
age and polymorbidity, which are independently associated with malnutrition.



US recommendations on cutaneous lymphoma management (pre-proof)
United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas. The authors

propose strategies for treating patients with primary cutaneous lymphoma, including lesions categorization and emphasis on
telemedicine.



STS guidelines on triaging cardiac surgery patients during the COVID-19 pandemic
The guidelines are on behalf of the Society of Thoracic Surgeons (STS) COVID-19 Taskforce and the Workforce for Adult
Cardiac and Vascular Surgery. Guidance provided to the adult cardiac surgery perioperative community regarding
management of patients considered or scheduled for surgical procedures in the context of the current pandemic.



Hematopoietic cell transplantation and cellular therapy: ASTCT statement
The American Society for Transplantation and Cellular Therapy (ASTCT) Pharmacy Special Interest Group (SIG) Steering
Committee provides this position statement for pharmacy practice management and clinical management recommendations
for COVID-19 in HCT and cellular therapy recipients.

Testing


ELISA testing shows infection rates 40 times higher than known cases in Los Angeles
A study of 863 Los Angeles county residents found 4.1% of adults tested positive for COVID-19 antibodies indicating they had
the virus in the past. This suggests a lower death rate and a rate of infection 40 times more than the number of confirmed
cases, which mirrors the results from a preprint describing an earlier study from Stanford University. If confirmed, the
estimates also suggest that disease prediction models and public health strategies need to be changed. However, antibody
tests come under increasing scrutiny recently over a high number of false positives reported in the kits.



FDA authorizes first at-home sample collection for LabCorp's COVID-19 test
60,000 at-home diagnostic kits are now available to eligible patients for $119. Healthcare workers will be given priority. The
samples collected by these kits show no difference in quality or results. The test results can be expected within 2 days after
the sample is received.



Diagnosis via ELISA effective in middle and late stage disease
Serodiagnostic power of the specific IgM and IgG antibodies against SARS-CoV-2 was investigated using enzyme-linked
immunosorbent assay (ELISA) to evaluate sensitivity, specificity, positive predictive value (PPV), negative predictive value
(NPV) and consistency rate. Results revealed that antibodies can be detected in the middle and later stage of the illness.



CRISPR testing as accurate as PCR in 45 min
Return results in about 45 minutes with comparable accuracy to that of conventional RT-PCR testing.



US researchers suggest better coordination for testing at an institutional and national level
A survey of more than 4,000 researchers. Results suggest that coordination could make hundreds of thousands more tests
for coronavirus available.

Promising Drugs, Vaccines, Therapies, Clinical Trials


Post-exposure prophylaxis for COVID-19 with hydroxychloroquine
In one Korean long-term care hospital, post-exposure prophylaxis (PEP) with HCQ was done in 189 patients and 22 healthcare
workers (HCWs) who were COVID-19-negative by PCR. PEP was completed in 184 (97.4%) patients and 21 (95.5%) HCWs
without serious adverse events. At the end of 14 days of quarantine, follow-up PCR tests were all negative. There were no
untreated controls.



No evidence of clinical benefit from hydroxychloroquine therapy in a retrospective analysis in US
veterans hospitalized with COVID-19
MedRxiv preprint: In this non peer-reviewed, retrospective study, 97 COVID-19 patients were treated with
hydroxychloroquine (HCQ), 113 were treated with HCQ and azithromycin (AZ) and 158 did not receive HCQ. HCQ with or
without AZ did not reduce risk of ventilation, and there was an association with increased overall mortality in patients treated
with HCQ alone after adjustment for initial clinical characteristics via propensity scores.



52 new COVID-19 trials registered today at clinicaltrials.gov
Treatment trials: Echocardiographic Manifestation, Beneficial Effects of Interferon Beta 1a, Ganovo (Danoprevir) With
Ritonavir, Efficacy and Safety of Hydroxychloroquine, Glococorticoid Therapy, Prognostic Factors of Patients with COVID-19,
Clinical and Radiomic Model of COVID-19, Acute Kidney Injury, Lopinavir/Ritonavir, Ribavirin and IFN-beta, Ayurveda,
Seroprevalence of MERS-CoV IgG, Impact of Swab Site, Pharmacokinetics of SAB-301, Pharmacokinetics and Immunogenicity,
Immunogenicity of Vaccine Candidate MVA-MERS-S, SARS Plasma by Apheresis, Alferon LDO, Streptokinase Versus
Unfractionated Heparin Nebulization. At time of writing, a total of 729 were active, 33 completed, and 3 posted results.

Other Science


Coagulation disorders in coronavirus
Review: Dysregulation of the coagulation cascade and the subsequent formation of intra-alveolar or systemic fibrin clots are
prominent findings in coronavirus infections associated with severe respiratory disease and have been demonstrated in both
humans and animal models. They can be attributed to the prothrombotic response, which attempts to prevent diffuse
alveolar hemorrhage, but can instead result in overt clot formation with detrimental effects in patient recovery and survival.



Severe COVID-19 disease is associated with cardiac injury and portends a poor prognosis
A systemic review and meta-analysis of 28 studies found that patients with severe COVID-19 disease are associated with
cardiac injury and that cardiac injury biomarkers were found to be elevated mostly in non-surviving COVID-19 patients. Meta
regression suggested that cardiac injury biomarker differences of severity are related to history of hypertension



Features of anosmia in COVID-19
A retrospective study of 54 patients with anosmia: the symptom began 4.4 (+/-1.9) days after infection onset. The mean
duration of anosmia was 8.9 (+/-6.3) days and 98% of patients recovered within 28 days.



In-hospital mortality higher in patients with admission D-dimer > 2 ug/ml
Measuring D-dimer has been recommended for COVID-19 patients. D-dimer of 2.0 ug/ml on admission may be optimum
cutoff as those patients had significantly higher in-hospital mortality (sensitivity = 92%, specificity = 83%). D-dimer may
improve management as it is an early predictive marker.



Early warning score based on age, chronic disease, NLR, CRP, D-dimer to predict clinical deterioration
MedRxiv preprint: Early Warning Score (EWAS) [0-4.5] is a useful tool for rapid triage and direction of management. Both
cohorts of this experiment had increased rates of clinical deterioration in patients with: older age, pre-existing chronic
disease, elevated D-dimer, elevated neutrophil to lymphocyte ratio, and elevated CRP. D-dimer >.8 mg/L found to have
greatest hazard ratio. Low-risk patients should be isolated and treated in "mobile cabin hospitals", medium-risk patients in
general wards, and high-risk patients in ICU.



Review of artificial intelligence in diagnosing COVID-19
The authors review the rapid responses in the community of medical imaging (empowered by AI) toward COVID-19. AIempowered image acquisition can help automate the scanning procedure and reshape the workflow with minimal contact to
patients, providing the best protection to the imaging technicians. Also, AI can improve work efficiency by accurate
delineation of infections in X-ray and CT images, facilitating subsequent quantification
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